KKR Sells $857M in BrightSpring Health Services Stock
BTSG has more than doubled off its 52-week low of $19.01 on elevated volume (2.8× avg).
Summary
KKR, a 10% owner, sold $857 million worth of BrightSpring Health Services stock in an open market transaction, significantly reducing its holdings as part of a secondary offering.
Key Events · Ownership and Investor Activity · BTSG
-
Major Share Sale by KKR
KKR Group Partnership L.P. and related entities, a 10% owner, sold 14,669,771 shares of BrightSpring Health Services common stock.
-
Substantial Transaction Value
The open market sale generated $857,492,124 in proceeds, representing 7.7% of the company's market capitalization.
-
Significant Stake Reduction
This transaction reduced KKR's total holdings by approximately 35%, indicating a major distribution of their investment.
-
Secondary Offering Execution
This Form 4 confirms the execution of KKR's portion of the secondary offering by selling stockholders, which was announced earlier today.
Analysis · BTSG · Finance
KKR Group Partnership L.P. and related entities, a major 10% owner, executed a substantial open market sale of BrightSpring Health Services common stock, disposing of over 14.6 million shares for $857 million. This transaction represents a significant reduction of KKR's stake (35% of their prior holdings) and confirms the execution of the secondary offering by selling stockholders announced earlier today.
How filings like this one have moved
In the 30 days to Sep 17, 2026, 35.7% of the 1179 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.44%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BTSG was trading at $58.00 on NASDAQ in the Finance sector, with a market capitalization of approximately $11.1B. The 52-week trading range was $19.01 to $62.11. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.